EDGAR Filing Documents for 0001193125-13-283304

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001193125-13-283304

Filing Date

2013-07-05

Accepted

2013-07-05 06:11:02

Documents

Period of Report

2012-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F/A	d563116d20fa.htm	20-F/A	2072496
2	EX-4.13	d563116dex413.htm	EX-4.13	3969
3	EX-8.1	d563116dex81.htm	EX-8.1	6546
4	EX-12.1	d563116dex121.htm	EX-12.1	9314
5	EX-12.2	d563116dex122.htm	EX-12.2	9352
6	EX-13.1	d563116dex131.htm	EX-13.1	4762
7	GRAPHIC	g563116tx_pg077logo.jpg	GRAPHIC	9688
	Complete submission text file	0001193125-13-283304.txt		2120949

Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077

Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088

NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F/A | Act: 34 | File No.: 000-29962 | Film No.: 13954870
SIC: 2834 Pharmaceutical Preparations